Sanofi expects 50 pc Indian market share for flu vaccines

Sanofi Pasteur India Tuesday said it expects 50 percent market share of vaccines for influenza (flu) in the country this year.

Last Updated: Aug 30, 2011, 22:46 PM IST

Mumbai: Sanofi Pasteur India Tuesday said it expects 50 percent market share of vaccines for influenza (flu) in the country this year.
"We are the market leader and expect to sell one million dosage of vaccine for flu in the country this year. This will help us in achieving 50 percent market share for flu vaccines, which is growing at 30 percent per annum," Sanofi Pasteur India Executive Director Joselito Sta Ana told reporters here.

The company has entered the Indian market in 2003 and become the leading player in flu vaccines market.
Sanofi Pasteur, the vaccines division of Sanofi produces 160 million doses per annum of vaccines for flu worldwide and India's demand of one million vaccines will be met through its plant in France, Joselito said.
Sanofi Pasteur is committed to protecting and improving human health worldwide. We believe there is a need for more awareness about influenza in India, Joselito said, adding that the company plans to expand its market in rural India through
various awareness programmes.
The company on Tuesday launched 'Mothers Against Flu', a facebook community of mothers. The company has roped in actress Raveena Tandon for the campaign.
This platform unites mothers from different parts of India with a single objective - to protect their children from the flu virus by creating awareness about the steps they can take to protect against and prevent flu and child care in

In India, Influenza (often referred to as 'flu') though prevalent all year round, peaks during the monsoon (July -September) and then again in winter (November-February). Flu should not be confused with common cold as flu can lead to serious and severe complications.
Everyone is at risk of being infected with the influenza virus and can spread the disease to others and children are particularly susceptible, the company said.
The Center for Disease Control and Prevention (CDC) recommends that everyone who is six months and older should get vaccinated against 'flu' every year, in order to be protected against the disease, it added.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs.
Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.